- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07736027
Effect of Hormone Replacement Therapy on Physiotherapy Outcomes in Postmenopausal Women With Frozen Shoulder
The Effects of Hormone Replacement Therapy on Clinical and Functional Outcomes in Postmenopausal Women With Frozen Shoulder
연구 개요
상태
상세 설명
This study investigates the impact of Hormone Replacement Therapy (HRT) on treatment outcomes in postmenopausal women undergoing a standardized physiotherapy program for frozen shoulder (adhesive capsulitis).
Participants are divided into two groups based on their current HRT status: postmenopausal women receiving HRT and those not receiving HRT. Both groups participate in the same structured physiotherapy program.
Assessments are conducted at baseline and after the intervention using the following outcome measures:
Primary Outcome Measures: Pain intensity evaluated by the Numeric Pain Rating Scale (NPRS) and shoulder pain and disability evaluated by the Shoulder Pain and Disability Index (SPADI).
Secondary Outcome Measures: Shoulder Range of Motion (ROM) measured by goniometry, sleep quality assessed via the Pittsburgh Sleep Quality Index (PSQI), menopause-specific quality of life measured by the Menopause-Specific Quality of Life Questionnaire (MENQOL), cognitive response to pain evaluated by the Pain Catastrophizing Scale (PCS), and overall treatment perception evaluated by the Global Rating of Change (GROC) scale.
By comparing these parameters, the study aims to elucidate whether systemic HRT modulates pain perception, functional recovery, and general quality of life during physical rehabilitation in postmenopausal women with frozen shoulder.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Şükran Acar, Master of Science Candidate
- 전화번호: +905346071963
- 이메일: acarsukran58@gmail.com
연구 연락처 백업
- 이름: Derya Çelik, Prof. Dr.
- 전화번호: +905327940169
- 이메일: derya.celik@iuc.edu.tr
연구 장소
-
-
Kadikoy
-
Istanbul, Kadikoy, 터키 (Türkiye), 34710
- Centro Reformer Pilates Center
-
연락하다:
- Şükran Acar, MSc Candidate
- 전화번호: +905346071963
- 이메일: acarsukran58@gmail.com
-
연락하다:
- Derya Çelik, Prof.Dr.
- 전화번호: +905327940169
- 이메일: derya.celik@iuc.edu.tr
-
수석 연구원:
- Şükran Acar, MSc Candidate
-
부수사관:
- Derya Çelik, PROF.DR.
-
부수사관:
- Çiğdem Yayla Abide, PROF.DR.
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Postmenopausal female patients aged 40 to 60 years.
- Shoulder pain at rest and during activities of daily living lasting for more than 3 months.
- Clinical diagnosis of Stage I or Stage II frozen shoulder (adhesive capsulitis).
- Passive range of motion (ROM) loss of greater than 25% compared to the unaffected shoulder in at least two movement planes (flexion, abduction, internal rotation, or external rotation).
- Reduced range of motion of less than 50% compared to the unaffected side in at least one movement direction (flexion, abduction, internal rotation, or external rotation).
- Increased restriction of external and internal rotation during glenohumeral abduction from 45 to 90 degrees.
Exclusion Criteria:
- Passive external rotation range of motion of less than 30 degrees (<30°).
- Presence of glenohumeral arthritis confirmed by radiography.
- History or presence of inflammatory joint disease.
- History of malignancy or active cancer diagnosis.
- Previous treatment for the current shoulder condition (e.g., physiotherapy and rehabilitation, intra-articular injections, or surgical intervention).
- Baseline shoulder pain score of less than 3 (<3) on the Numeric Pain Rating Scale (NPRS).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: HRT Group
Postmenopausal women diagnosed with primary frozen shoulder who are receiving hormone replacement therapy and undergoing the standardized physiotherapy program.
|
A standardized and supervised shoulder physical therapy and rehabilitation program delivered face-to-face in a clinical setting by an expert physiotherapist over 12 weeks (2 sessions per week, 50-60 minutes per session), supplemented by a prescribed home exercise program.
The program includes patient education, stretching exercises, active-assisted and active range of motion (ROM) exercises, glenohumeral and scapular mobilization, progressive strengthening exercises, and post-treatment cryotherapy.
Exercise progression is individualized based on participants' demographic characteristics, pain levels, progressive overload principles, and subjective feedback.
Following each session, participants are routinely monitored for any exercise-related adverse effects.
다른 이름들:
|
|
활성 비교기: Non-HRT Group
Postmenopausal women diagnosed with primary frozen shoulder who are not receiving hormone replacement therapy and undergoing the standardized physiotherapy program.
|
A standardized and supervised shoulder physical therapy and rehabilitation program delivered face-to-face in a clinical setting by an expert physiotherapist over 12 weeks (2 sessions per week, 50-60 minutes per session), supplemented by a prescribed home exercise program.
The program includes patient education, stretching exercises, active-assisted and active range of motion (ROM) exercises, glenohumeral and scapular mobilization, progressive strengthening exercises, and post-treatment cryotherapy.
Exercise progression is individualized based on participants' demographic characteristics, pain levels, progressive overload principles, and subjective feedback.
Following each session, participants are routinely monitored for any exercise-related adverse effects.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change from Baseline in Shoulder Function and Disability Scores using Shoulder Pain and Disability Index (SPADI)
기간: Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
Shoulder pain and disability will be assessed using the Turkish version of the Shoulder Pain and Disability Index (SPADI).
The index consists of 13 items divided into two subscales: pain (5 items) and disability (8 items).
Each item is scored on a 0-10 numerical rating scale.
For the pain subscale, 0 indicates "no pain" and 10 indicates "worst imaginable pain".
For the disability subscale, 0 indicates "no difficulty" and 10 indicates "so difficult that help is required".
Subscale scores and total SPADI scores are calculated, ranging from 0 to 100, where higher scores indicate greater pain severity and functional disability.
|
Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
|
Change from Baseline in Shoulder Pain Intensity Scores using Numeric Pain Rating Scale (NPRS)
기간: Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
Shoulder pain intensity will be assessed using the 11-point Numeric Pain Rating Scale (NPRS), where 0 represents "no pain" and 10 represents "worst imaginable pain".
Participants will rate their pain levels separately at rest and during movement.
Higher scores indicate greater pain severity.
|
Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change from Baseline in Active and Passive Shoulder Range of Motion (ROM)
기간: Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
Active and passive shoulder range of motion (flexion, abduction, internal rotation, and external rotation) will be assessed in degrees using a universal goniometer according to standardized goniometric measurement protocols.
Higher degree values indicate better mobility.
|
Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
|
Change from Baseline in Menopause-Specific Quality of Life Questionnaire (MENQOL) Scores
기간: Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
Health-related quality of life will be evaluated using the Menopause-Specific Quality of Life Questionnaire (MENQOL).
The questionnaire consists of 29 items divided into four domains: Vasomotor (3 items), Psychosocial (7 items), Physical (16 items), and Sexual (3 items).
Items are scored on a 7-point Likert scale ranging from 0 (not at all bothered) to 6 (extremely bothered).
Domain scores and total scores are calculated, with higher scores indicating a greater impact of menopausal symptoms and lower quality of life.
|
Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
|
Change from Baseline in Pain Catastrophizing Scale (PCS) Scores
기간: Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
Pain-related catastrophizing thoughts and behaviors will be evaluated using the Pain Catastrophizing Scale (PCS).
The 13-item self-report questionnaire assesses three dimensions: Rumination (4 items), Magnification (3 items), and Helplessness (6 items).
Items are rated on a 5-point Likert scale ranging from 0 ("not at all") to 4 ("all the time").
Total scores range from 0 to 52, with higher scores indicating higher levels of pain catastrophizing.
|
Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
|
Overall Patient-Perceived Improvement Measured by 5-Point Global Rating of Change (GROC) Scale
기간: Week 6, Week 12, and 3-month follow-up (Week 24)
|
Participants' overall perception of improvement or worsening in their shoulder condition will be assessed using a 5-point Global Rating of Change (GROC) scale.
The scale ranges from 1 ("much worse") to 3 ("no change") to 5 ("much better").
Higher scores indicate greater perceived overall improvement in shoulder function and symptoms.
|
Week 6, Week 12, and 3-month follow-up (Week 24)
|
|
Change from Baseline in Pittsburgh Sleep Quality Index (PSQI) Scores
기간: Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
Sleep quality and disturbances over the past month will be evaluated using the Pittsburgh Sleep Quality Index (PSQI).
The 19-item self-report questionnaire generates seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.
Each component is scored from 0 to 3, yielding a global score ranging from 0 to 21.
Higher global scores indicate poorer sleep quality, with a total score greater than 5 indicating poor sleep quality.
|
Baseline, Week 6, Week 12, and 3-month follow-up (Week 24)
|
공동 작업자 및 조사자
수사관
- 연구 책임자: DERYA ÇELİK, PROF.DR., Istanbul University - Cerrahpasa
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- IUC-oThQlo0H
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .